Morishita Jintan to Exhibit at 'Health Food Ingredients & OEM Expo 2026' and Host Seminars on Cassis Extract for Growing Eyecare Market

Morishita Jintan Co., Ltd. (Headquarters: Osaka, President: Yuji Morishita) will participate in the 'Health Food Ingredients & OEM Expo 2026,' a business exhibition for health food ingredient supply and contract manufacturing, for two days from April 16 (Thursday) to 17 (Friday), 2026, at Tokyo International Forum Hall E1. The company will introduce functional ingredients (rosehip extract, cassis extract) and widely disseminate information on the diversity and versatility of seamless capsules and tablets. In response to the increasing internet usage due to the spread of digital devices and the growing demand in the eyecare market, the company will introduce 'Cassis Extract,' an eyecare ingredient. Seminars will also be held, presenting the functionality and appeal of cassis extract. Seminar Title: 'Experience the effect with a single dose! Cassis extract expands possibilities for eyecare product development.' Dates: April 16, 2026 (Thursday) 12:30-12:55 (Seminar Room 5), April 17, 2026 (Friday) 14:50-15:15 (Seminar Room 5). Key points of the exhibition and seminar include: Seminar and booth exhibition for eyecare ingredient 'Cassis Extract MJ,' a unique ingredient aiming for differentiation with immediate effect and dual health claims. Booth exhibition for body fat (visceral fat) reduction ingredient 'Rosehip Polyphenol MJ,' an ingredient that supports ideal product development by minimally affecting the flavor and color of added foods. Contract manufacturing of various formulations, addressing product development challenges with seamless capsule and tablet formulation technologies. 'Cassis Extract' is a 100% pure extract from New Zealand cassis fruits, commonly used as an eyecare ingredient. It standardizes the total amount of four anthocyanins, including two types of rutinoside glycosides. It has a proven track record as a 'Food with Function Claims' ingredient (daily intake: 50mg/day as cassis anthocyanin, 167mg/day as extract powder). 'Rosehip Extract' is an extract from whole rosehip fruits, including seeds, with the functional component being rosehip-derived tiliroside. Rosehip-derived tiliroside has been reported to promote fat metabolism and reduce body fat. It is characterized by less bitterness and astringency unique to plant extracts, minimally affecting the appearance and taste of applied products. It is a water-soluble powder extract that is effective in small amounts (daily intake: 0.1 mg/day as rosehip-derived tiliroside, 100mg/day as extract powder). Dedicated website: https://rosehip-tiliroside.com/. For 'Seamless Capsules,' the company offers OEM services utilizing its proprietary 'seamless capsule' technology, which can encapsulate powders to liquids and impart various functions such as acid resistance and heat resistance to the film. Total support is provided from planning, design, manufacturing, to packaging. For 'Tablets,' MJ Shiga, a former pharmaceutical formulation (tablet) manufacturer's factory, has become a group company and has started tablet OEM services. The factory is certified for pharmaceutical manufacturing and health food GMP. Leveraging its expertise, it supports customers in solving challenges such as difficult-to-tablet materials and reducing the number of tablets, realizing differentiated product creation. Morishita Jintan Co., Ltd. was founded in February 1893 and established in November 1936. Its main businesses include the manufacturing and sales of pharmaceuticals, quasi-drugs, medical devices, and food products. URL: https://www.jintan.co.jp/. The company celebrated its 130th anniversary on February 11, 2023, and formulated its purpose to further enhance corporate value.